Detalles de la búsqueda
1.
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
Breast Cancer Res Treat
; 110(2): 327-35, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17851757
2.
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
J Clin Oncol
; 23(25): 5960-72, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16087945
3.
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.
J Clin Oncol
; 27(27): 4522-9, 2009 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19687336
Resultados
1 -
3
de 3
1
Próxima >
>>